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http://www.chiromt.com/content/20/1/36RESEARCH Open AccessSkeletal muscle contractility, self-reported pain
and tissue sensitivity in females with neck/
shoulder pain and upper Trapezius myofascial
trigger points– a randomized intervention study
Corrie Myburgh1,2*, Jan Hartvigsen1,2, Per Aagaard1 and Anders Holsgaard-Larsen3Abstract
Background: In relation to Myofascial Triggerpoints (MFTrPs) of the upper Trapezius, this study explored muscle
contractility characteristics, the occurrence of post-intervention muscle soreness and the effect of dry needling on
muscle contractile characteristics and clinical outcomes.
Methods: Seventy-seven female office workers (25-46yrs) with and without neck/shoulder pain were observed with
respect to self-reported pain (NRS-101), pressure-pain threshold (PPT), maximum voluntary contraction (Fmax) and
rate of force development (RFD) at baseline (pre-intervention), immediately post-intervention and 48 hours
post-intervention. Symptomatic and asymptomatic participant groups were each randomized into two treatment
sub-groups (superficial (SDN) and deep dry needling (DDN)) after baseline testing. At 48 hours post-intervention
participants were asked whether delayed onset muscle soreness (DOMS) and/or post-needling soreness had
developed.
Results: Muscle contractile characteristics did not differ between groups at baseline. Forty-six individuals developed
muscle soreness (39 from mechanical testing and seven from needling). No inter-group differences were observed
post-intervention for Fmax or RFD for the four sub-groups. Over the observation period, symptomatic participants
reported less pain from both SDN (p= 0.003) and DDN (p=0.011). However, PPT levels were reduced for all
participants (p=0.029). Those reporting DOMS experienced significant decreases in PPT, irrespective of symptom
state or intervention (p=0.001).
Conclusions: In selected female neck/shoulder pain sufferers, maximum voluntary contraction and rapid force
generation of the upper Trapezius was not influenced by clinically relevant self-reported pain or the presence of
diagnostically relevant MFTrPs. Dry needling, deep or superficial, did not affect measured functional outcomes over
the 48-hour observation period. DOMS affected participants uniformly irrespective of pain, MFTrP status or
intervention type and therefore is like to act as a modifier.
Trial registration: Clinical Trials.gov- NCT01710735
Significance and Innovations: The present investigation is one of the first to examine the hypothesis of gross
muscle contractile inhibition due to the presence of diagnostically relevant MFTrPs.
Individuals suffering from clinically relevant levels of self-reported pain are able to tolerate maximum voluntary
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contraction testing, but delayed onset muscle soreness (DOMS) is a likely side-effect irrespective of symptom status.
As a consequence, its confounding effect during subsequent testing must be taken into account.
Keywords: Myofascial pain, Trigger points, Neck/shoulder pain, Mechanical outcomesBackground
Musculoskeletal problems of the neck/shoulder region
are a growing 21st century health care concern [1]. The
prevalence of long standing musculoskeletal illness in
Denmark is estimated at around 13% and approximately
20% of the adult Danish population has experienced pain
in the neck region during the previous month [2]. Fur-
thermore, neck/shoulder pain more commonly affects
women than men [1].
The study, identification and treatment of hyperirrita-
ble skeletal muscle fibers, known as myofascial trigger
points (MFTrPs or TrPs) have emerged as an important
category within the area of general musculoskeletal pain
[3-5]. Epidemiological data specific to Myofascial Pain
Syndrome (MPS) is still somewhat unclear, but the mean
prevalence of the condition among adults aged 30 to 60
years is estimated at 37% for men and 65% for women
[6].
MFTrPs are typically identified through a combination
of manual palpation and patient feedback [7,8]. During
this process, referred to as global assessment (GA), the
examiner establishes whether presenting symptoms such
as local and referred pain, match the location and pat-
terns of referral known to exist in relation to TrPs of a
particular muscle. GA has been found to be a valid and
reliable manner in which to establish the diagnostic rele-
vance of MFTrPs (also referred to as an ‘active’ TrP) [7].
A TrP that is not associated with the presenting clinical
picture can be termed ‘latent’.
An important issue, which continues to hamper the
development of the understanding of MFTrP phenom-
ena, relates to a relative dearth in measurable outcomes
demonstrating pathophysiology. For example, it has been
argued that that skeletal myofibers may fatigue prema-
turely and may be weakened due to autogenic reflex in-
hibition of the tissues containing MFTrP(s) [9,10].
Although plausible, this theory remains essentially un-
substantiated and robust measures are required to ob-
serve the mechanical and neuromuscular behavior of
affected musculature [11]. Thus, as an initial step to fully
understand what might be expected with respect to
gross muscle contractility, an assessment of the muscles
mechanical properties is required.
In the exercise and occupational health sciences, the
maximum voluntary contraction force (Fmax), and the
capacity for rapid force generation, so-called rate of
force development (RFD), are routinely used to quantifymechanical and neuromuscular parameters in intact
human skeletal muscle [12-15]. Studies have demon-
strated reduced Fmax and RFD among females with
chronic neck muscle pain compared to asymptomatic
controls [14,15]. However, these parameters do not seem
to have been evaluated in the MFTrP context. An aspect
that perhaps limits the use of maximum voluntary con-
traction characteristics is the propensity of test subjects
to develop delayed onset of muscle soreness (DOMS)
[16-18]. This well-known phenomenon is commonly
experienced within 24 hours after unaccustomed exer-
cise, typically lasting for 1 to 4 days. DOMS typically is
characterized by a painful sensation when contracting,
stretching, or exerting pressure on the stressed muscle.
Consequently, self-limiting increased tissue sensitivity,
pain and decreases in maximum muscle force have been
observed in relation to DOMS [18].
As an intervention, dry needling holds promise for the
clinical resolution of MFTrPs implicated in MPS [19,20].
Two sub-types, superficial (SDN) and deep dry needling
(DDN) techniques are routinely applied in the clinical
setting. SDN is thought to achieve its effect indirectly,
inhibiting C fiber pain impulses, where as DDN stimu-
lates affected muscle directly, causing rapid depolarization
of affected fibers in the area of the MFTrP nidus. DDN
appears to affect clinical outcomes more strongly, but also
gives rise to post-needle soreness; a side effect stemming
from the repeated insertions, required to abolish local
twitch responses (LTR) [20,21].
To start exploring the viability of muscle testing as an
outcome measure in relation to MFTrPs, the present
study intended to determine whether contractile muscle
characteristics are affected by clinically relevant MFTrPs,
whether post-intervention muscle soreness and DOMS
affects clinical and/or mechanical outcomes and whether
muscle characteristics (Fmax and RFD) and clinical out-
comes are affected by dry needling.
The specific objectives study were (i) whether Fmax
and/or RFD differ significantly between symptomatic
and asymptomatic individuals, (ii) if post-testing DOMS
was reported in relation to symptom status and/or depth
of needling, (iii) if post-needling soreness occurred in re-
lation to symptom status and/or depth of needling (iv)
whether dry needling of a clinically relevant MFTrP
influences self-reported pain, tissue sensitivity and max-
imum voluntary contraction and (v) whether DOMS is
likely to act as a modifier.
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Design
A randomized, intervention study conducted in a human
performance laboratory.
Study population
Through local newspaper adverts responses were soli-
cited from females aged 20 and 46 years, performing
office work for four hours or more a day. These criteria
were aimed at limiting age related variation in strength
reductions and MFTrP prevalence [22]. It is unclear
whether occupational mechanical overload (either acute
or chronic) is associated with elevated prevalence of
MFTrPs, however, in order to reduce heterogeneity we
sampled participants sharing a common risk factor [23].
A drawing, corresponding with the area covered by the
upper Trapezius muscle was provided to clarify our
study target area. Both individuals suffering from neck/
shoulder pain and pain free persons were encouraged to
respond in order to create a case mix. This enabled us
to create four sub-groups (two asymptomatic and two
symptomatic). A project administrator screened respon-
dents telephonically.
Respondents were excluded if they presented with a
history of chronic, systemic pathology (e.g. hemophilia),
pre-existing neck/shoulder pathology/surgical proce-
dures, suffered clinical depression, were involved in
health-related legal action, were likely to be pregnant,
used anti-inflammatory and/or chronic pain medication,
had received dry needling for a shoulder/neck disorder
within 6 months prior to the study (to raise the level of
patient naiveté), suffered from needle phobia or had a
body-mass index (BMI) ≥ 31. The BMI criterion was
aimed at reducing sample heterogeneity due to large
variation between soft tissues present over the shoulder
area.
After agreeing to participate, an information letter and
background questionnaire was posted to the subjects
electronically. The questionnaire was adapted from simi-
lar musculoskeletal investigations conducted in the
workplace context [24]. A consultation date within 5
days of the telephonic contact was then scheduled.
Clinical evaluation
Subjects presented to the Institute of Sport Science and
Clinical Biomechanics, University of Southern Denmark.
An evaluation was conducted by an experienced muscu-
loskeletal clinician (CM) with 15 years exposure to
MFTrP evaluation, who confirmed general study eligibil-
ity inclusion/exclusion criteria, determined symptom-
atic/asymptomatic status and MFTrP status, gathered
anthropometrical data and randomized participants.
Our operational definition of neck and/shoulder pain
was pain in the region of the upper Trapezius muscles,therefore only participants satisfying this criteria could
qualify as symptomatic for the purposes of this study [9].
A cut-point was established that defined a participant
with a score ≥3 on the NRS-101, as a symptomatic sub-
ject [25]. This criterion was introduced in order to ex-
clude participants presenting with clinically irrelevant
levels of self-reported pain.
The diagnostic relevance of MFTrPs was established
by means of clinician global assessment. GA is both a re-
liable method for evaluating MFTrPs and allows for the
distinction between so-called ‘active and latent’ TPs [7].
Furthermore, participants found to have clinically rele-
vant MFTrPs capable of referring pain overlapping with
that of the upper Trapezius musculature were excluded
from the study, these included: the cervical Multifidi,
Splenius cervicis, Levator Scapulae, Supraspinatus, Infra-
spinatus and Scalenes [9]. The distinction between
symptomatic and asymptomatic individuals in this study
therefore rested on the intensity of self-reported pain
and the presence of a diagnostically relevant (active)
MFTrP in the upper Trapezius muscle.
Our specific criteria for the symptomatic group there-
fore were: a clinically relevant MFTrP of the upper Tra-
pezius musculature and self- reported pain of ≥3 on an
eleven-point numerical pain rating scale (NRS-101). Our
specific criteria for the asymptomatic group were: ab-
sence of a clinically relevant MFTrP of the upper Tra-
pezius musculature and self-reported pain of 0.
Respondents who did not meet the specific criteria for
either group were excluded.
Randomisation
Participants were allocated into particular sub-groups,
using computer generated random numbers tables. Two
tables were generated, one for symptomatics, the other
for asymptomatics. Each contained the numbers 1-50,
allocated prior to the study to a 0 (DDN) or 1(SDN)
group. As participants were inducted, their participant
number would thus randomly correspond to a group.
Evaluation of mechanical muscle function
Measurements of maximal isometric muscle force
(Fmax), and rate of force development (RDF), were per-
formed for the shoulder elevators (shoulder joint posi-
tioned in an anatomic neutral position and elbow
extended) and shoulder abductors (shoulder joint posi-
tioned in an anatomic neutral position and elbow joint
in 90o of flexion) (Figure 1). Subjects were seated and
strapped in a custom-built isometric shoulder elevation/
abduction dynamometer chair based upon strain-gauge
technology, connected to a computer with custom devel-
oped software (MathWorks, MatLab) [15]. The strain-
gauge signals were immediately converted into Newton
(N), and stored digitally for further analysis. The chair
Figure 1 Trapezius Dynamometer. Trapezius Dynamometer in the
shoulder elevation test position. The dynamometer consists of A)
Strain Gauge force transducers, B) Adjustable slide rail to
individualize height, C) Shoulder pad, and D) Adjustable seat to
ensure no contact between feet and ground.
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thropometrics (i.e. chair height, where the subjects feet
were not allowed to touch the ground, backrest height,
shoulder height and shoulder distance). These adjust-
ments were made for both the position of elevation test
and then for the abduction test. Individual settings were
noted and used at every test occasion. Fmax and RFD
measured in the initial 200ms from the instant of con-
traction onset (RFD200 ms) were determined for the
shoulder elevators and abductors (intervention side only)
in all four sub-groups. Instant of contraction onset was
operationalized as the first observable deviation of the
signal from baseline. Shoulder elevation was tested first,
followed directly by the abduction test directly after. For
both shoulder elevation and abduction, subjects were
instructed to contract as explosively and forcefully as
possible. Verbal encouragement during testing and on-
line visual feedback of the instantaneous dynamometer
force on a computer screen was provided. Contraction
duration was 6 seconds and successive contractions were
performed ad libitum until no further increase in Fmax
could be observed. Fmax was measured for each contrac-
tion and the contraction with highest Fmax from each test
was selected for further analysis. Mechanical muscle data
were recorded at baseline, immediately post needling and48 hours after dry needle insertion treatment. The test-
procedure was performed bilaterally but only unilateral
data from the affected side (for symptomatic) or one side
randomly chosen (for asymptomatic) was used. Before
tests, participants performed a standardized warm up
routine for the neck and shoulders.
Pain-related outcome measures
Self-reported pain (NRS-101 eleven point pain rating
scale) and pressure-pain threshold (PPT) algometry are
commonly employed as clinical outcomes in MPS re-
search to observe subjective pain experience and tissue
sensitivity, respectively [26,27]. The former parameter was
recorded at baseline and at 48 hours post-intervention,
whilst the latter was recorded at baseline, immediately
post-intervention and 48 hours post-intervention. PPT
measures were obtained from MFTrP sites in symptom-
atic participants or typical Trapezius MFTrP location
‘reference sites’ in asymptomatic participants [9]. Specific
sampling sites were marked with permanent ink during
evaluation and covered with a waterproof plaster. Partici-
pants were also asked not to wash or touch the area if
possible. All PPT values were recorded in kilopascal.
Post-needling soreness and post-testing DOMS
At 48 hours post-intervention evaluation, we asked par-
ticipants: Did you experience an increase in muscle dis-
comfort and/or soreness starting the day after the first
examination? In cases where soreness had developed,
we further discerned whether participants felt the sore-
ness due to needling (unilateral in the proximity of nee-
dle insertion), mechanical testing (diffuse and invariably
noted bilaterally) or both.
Intervention procedures
Dry needle insertion took place immediately after baseline
measurement. A 3” (25mm) acupuncture needle was used
in all needle procedures (Cloud and Dragon, Shanghai
Xinhua E-General Merchandise Co., Ltd). MFTrP stimula-
tion occurred on the side of which the subject showed
hand dominance, in the case of bilateral findings. Inter-
ventions were either in the form DDN [28] or SDN inser-
tion [20]. Participants were needled in a seated position,
making use of a supported treatment chair (Chattanooga
AdaptaWMC-100 Portable Massage Chair). In all instances,
a single dose of needling was administered immediately
after the baseline mechanical muscle evaluation. A repeated
insertion, clockwise fanning motion was used. Fanning is
thought to result in more favourable outcomes than single
insertion protocol, due to a higher likelyhood inducing
hyperstimulation analgesia and exhausting the MFTrP
twitch response [26].
In both symptomatic and asymptomatic (control) sub-
jects the needle depth was marked post-intervention and
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lute model no.cd-20cpx).
Deep dry needling
DDN of symptomatic participants was based on the ap-
pearance and exhaustion of the twitch response
phenomenon [29]. The twitch response is a reliable cri-
terion for the presence of trigger points when fibers in
the immediate vicinity of the MFTrP nidus are stimu-
lated [30,31]. The purpose of needling in this sub-group
therefore was to elicit and exhaust twitch responses with
repeated fanning needling insertion [32]. An experimen-
tal pilot protocol was developed on five non-participants
(with appropriate anthropometric characteristics), in
order to develop an idea of the needle penetration that
might be expected as well as the time that would be
required. We observed that, in order to repeatedly elicit
twitch responses, no less than 10mm of the needle had
to penetrate the epidermis over a period of 90 seconds.
As no twitch response would exist for asymptomatic
subjects, none could be induced. Therefore, the needles
were marked at 10mm pre-intervention, so that the in-
sertion depth would be similar to participants receiving
deep needle insertion.
Superficial dry needling
We standardised this procedure, by tapping (using the
index finger) the needle into the epidermis until it
remained erect and could support its own weight. Again
we piloted this protocol on 5 non-participants to deter-
mine what depth of penetration this resulted in. The
needle penetration depth was determined to be 5mm.
Current guidelines for superficial needling concurred
with our findings, suggesting an insertion depth of be-
tween 5-10mm [20]. No twitch response was expected
for symptomatic or asymptomatic subjects, therefore
intervention time was standardised to 90 seconds.
Blinding
Both participants and mechanical evaluation technicians
were blinded with respect to the type of intervention ap-
plied, i.e. superficial or deep needle insertion.
Statistical analysis
We estimated that optimal sub-group sizes for this study
would require data from 31 participants. The calculation
was based on detecting differences of 25% in self-reported
pain after treatment post-intervention, a 2-tailed test,
α=0.05 and a power of 80%. Normal distribution for the
dataset was not assumed, thus all evaluations were tested
using non-parametric statistics. Inter-group comparison
of symptomatic and asymptomatic subjects at baseline
was conducted using Mann–Whitney U tests for all out-
comes observed. The frequency of the development ofpost-intervention soreness was recorded and compared
between participant groups using the Mann–Whitney U
test. To analyse intra-group effects over time we con-
ducted firstly a Friedman’s test, in order to observe
whether median values in at least one group changed sig-
nificantly with respect to any of the others. Furthermore,
the Wilcoxon’s signed rank test was performed in order
to observe whether significant median value changes oc-
curred within sub-groups over time. Finally, inter-group
differences immediately after and 48 hours post-
intervention were analysed, again by means of the Mann–
Whitney U test. PPT, Fmax and RFD comparisons where
conducted at three time points, namely baseline (pre-inter-
vention), immediately post-intervention and at 48 hours
post-intervention, whereas self-reported pain (NRS-101)
comparisons were conducted only pre- and 48 hours post-
intervention. To determine whether age or BMI was signifi-
cantly correlated with self-reported pain, tissue sensitivity
or mechanical parameters observed, Spearman’s correlation
testing was performed. We also used a Bonferroni correc-
tion to adjust for multiple comparisons.
Means, medians, SDs and 95% CIs were calculated for
all dependent variables. We also calculated box plots to
compare the onset and development of DOMS. Statis-
tical significance was set at p≤0.05. All muscle strength/
RFD outcome measures were normalized relative to the
participant’s bodyweight in kilograms (N/kg). Data were
exported to STATA v11 (http://www.stata.com) and
IBMWSPSS v19 for statistical analysis.
Ethical clearance (S-20070094HJD) was granted
through the local ethics committee (Region of Southern
Denmark).
Results
Participants and baseline comparison
As illustrated in Figure 2 eighty-three candidates agreed
to the study conditions and signed a written inform con-
sent. During the course of the study six participants
were excluded; three were found to have a BMI of ≥ 31
(the participant BMI self-calculations were erroneous),
two participants elected not to complete the protocol
and one subject developed facet joint irritation in the mid
thoracic spine. Symptomatic (n=37) and asymptomatic
participants (n=40) were observed to be anthropometri-
cally similar, however, the median age of symptomatic
participants was 31 years, versus 24 in the asymptomatic
comparison group (p= 0.007) (see also Table 1). Of the
symptomatic subjects, 76% had consulted a health care
practitioner in the preceding 12 months over symptoms
in the neck/shoulder area, compared to 24% of asymp-
tomatic participants.
As expected, self-reported pain was significantly higher
among the symptomatic group (median= 5 versus 0)
(p<0.0001). No significant differences were observed at
48 hour post-intervention measurements: 
NRS-101, PPT, Fmax & RFD 
83 candidates identified from
advertisements 
3 participants excluded with BMI 
index >31 
Baseline measurements:  
NRS-101, PPT, Fmax & RFD 
General clinical and MFTrP screening 
Symptomatic 
DDN= 20 
Random allocation 
DDN procedure  
Asymptomatic 
DDN= 21 
Asymptomatic 
SDN= 20 
Symptomatic 
SDN= 20 
 SDN procedures 
Asymptomatic 
DDN= 21 
Symptomatic 
DDN= 18 
2 excluded 
due to non-
compliance 
Symptomatic 
SDN= 20 
Asymptomatic 
SDN= 20 
Post-intervention measurements: 
PPT, Fmax & RFD 
1 excluded due to 
development of 
thoracic facet joint 
irritation  
Symptomatic 
DDN= 17 
Asymptomatic 
DDN= 20 
Symptomatic 
SDN= 20 
Asymptomatic 
SDN= 20 
DOMS 
reported= 39 
No DOMS 
reported= 38 
Figure 2 Flow of participants, data collection points and outcome measures.
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cipants for PPT, Fmax or RFD (Table 1).
Onset of post-needling soreness and DOMS
At 48-hour post-intervention, 46 participants reported the
development of shoulder muscle soreness (39 mechanical
testing versus 7 needle insertion). Two symptomatic parti-
cipants receiving DDN and one receiving SDN attributedTable 1 Baseline comparison (means) of symptomatic and asy
All participants
(N= 77)
Age NRS-101 BMI PPT Fma
abd
Symptomatic (n=37) 46.07 58.35 40.09 38.55 36.4
Asymptomatic (n=40) 32.46 21.10 37.99 39.41 37.4
p-value 0.007 <0.0001 0.680 0.866 0.84their soreness to the combination of needling and mech-
anical testing. As indicated by Table 2, the proportion of
participants reporting muscle soreness due to mechanical
testing ranged between 45% and 57% and was unrelated
to symptoms or needling procedure. By contrast, muscle
soreness attributed to needle insertion was obser-
ved almost exclusively among symptomatic participants
receiving DDN.mptomatic participants
x-shoulder
uctors
Fmax- shoulder
elevators
RFD- shoulder
abductors
RFD- shoulder
elevators
9 33.20 35.00 33.69
7 39.62 38.84 39.16
2 0.193 0.440 0.267
Table 2 Participant perceived soreness 48 hours post-intervention
All participants (N=77) Sympt DDN Sympt SDN Asympt DDN Asympt SDN p- value
Soreness from strength test 39 (50.6%) 8 (47.1%) 9 (45.0%) 12 (57.1%) 10 (52.6%) 0.867
Soreness from needle intervention 7 (9.1%) 5 (29.4%) 1 (5%) 0 (0%) 1 (5.3%) 0.010
DDN= deep dry needling, SDN= superficial dry needling.
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Needle insertion depths
The comparative needle insertion depth was 6,0mm (SD
1.2) for SDN and 12,3mm (SD 2.2) for DDN (p<0.001).
Fmax and RFD
In the asymptomatic SDN group, Fmax was decreased
from baseline to post intervention (p=0.01), whilst RFD
increased between the baseline and 48-hour follow-up
assessment (p= 0.007). However, no other significant
changes were observed from baseline to follow-up in the
effect of SDN and DDN (See Additional file 1).
Self-reported pain
Both symptomatic intervention groups experienced a re-
duction in self-reported pain between baseline and
follow-up (Table 3) and no significant difference between
DDN and SDN was observed at 48 hours post-
intervention (p-values remained significant at the 0.05
threshold after Bonferroni multiple test adjustment) see
also Additional file 2. A statistically significant difference
remained between symptomatic and asymptomatic DDN
sub-groups at 48 hours (p<0.0001).
Pressure-pain threshold
PPT measures indicated that tissue sensitivity increased
significantly for the entire cohort over time (p=0.029).
However, DDN and SDN sub-group analysis indicated
no significant changes within or between group changes
immediately or 48 hours post-intervention see also
Additional file 3.
Effect of post-testing DOMS
Fmax and RFD
In the sub-group reporting DOMS, Fmax for shoulder ab-
duction increased between baseline and follow-up
(p=0.004). Maximum elevator strength was decreasedTable 3 Inter and intra-group comparison by symptom group
NRS-101 Baseline
Sub-
group
mean 95% CI median 95% CI mean 95% CI me
S DDN 5.59 4.68 6.50 5.00 4.00 7.00 3.41 2.31 4.52 4.00
S SDN 5.40 4.48 6.32 5.00 4.12 6.88 4.60 3.62 5.58 4.50
As DDN 0.24 0.00 0.48 0.00 0.00 0.00 0.71 0.10 1.33 0.00
As SDN 0.26 0.00 0.53 0.00 0.00 0.00 0.26 0.00 0.65 0.00
S= Symptomatic, As= Asymptomatic, DDN= deep dry needling, SDN= superficial dr
*P-values remained significant at the 0.05 threshold after Bonferroni multiple test aimmediately post-intervention, but returned to baseline
values 48 hours post-intervention. Similarly, RFD for
shoulder elevation initially fell below baseline values, but
then recovered over the subsequent 48-hour interval
(p≤0.0001). No significant inter-group comparison dif-
ferences were observed for either of these parameters.
Self-reported pain
A drop in self-reported pain was observed within the
group unaffected by muscle soreness (p=0.005)
(Figure 3A). In contrast, participants developing sore-
ness reported increasing levels of self-reported pain.
However, this observation did not reach statistical sig-
nificance for the inter-group comparison 48 hours post-
intervention.
Pressure-pain threshold
PPT among the participants reporting DOMS decreased
between baseline and follow-up (median change score
(MCS) -33.99) (p≤0.0001), but remained constant for
those unaffected by DOMS (MCS 3.49). At 48-hours
post-intervention, PPT was significantly depressed, indi-
cating increased tissue sensitivity for participants experi-
encing DOMS (p=0.001) (see Figure 3B).
Correlation analysis
As shown in Table 4, co-efficients ranged between
r= -0.449 (Fmax shoulder elevators) and r=0.050 (RFD
shoulder elevators), thus indicating no consistent relation-
ship to exist between age and maximum shoulder eleva-
tion strength capacity.
Discussion
Summary of findings
This study was, to the best of our knowledge, the first to
apply maximum voluntary muscle contraction testing to
the investigation of MFTrPs. Notably maximuming
NRS-101 48-hour F/U
dian 95% CI Within-group comparison (p-
value)
Between-group comparison
(p-value)
2.01 4.99 0.011* S DDN vs As DDN
p<0.00013.12 6.00 0.003*
0.00 0.55 0.041
0.00 0.00 0.040
y needling.
djustment.
Figure 3 Self-reported pain (A) and pressure-pain thresholds
(B) at baseline and after 48 hours in participants reporting the
development of soreness versus those not reporting soreness.
Table 4 Spearman’s correlation of age by mechanical parame
N=77 Fmax- shoulder abductors Fmax- shoulder elevators
Interval 1 2 3 1 2 3
Age (CC) -.102 -.160 -.170 -.285* -.380** -.449**
p-value .382 .167 .151 .013 .001 <0.0001
Interval 1= baseline, interval 2= immediately post-intervention, interval 3= 48 hours
significant at 0.05 (2-tailed).
Myburgh et al. Chiropractic & Manual Therapies 2012, 20:36 Page 8 of 10
http://www.chiromt.com/content/20/1/36contractile force (Fmax) and rapid force capacity (RFD)
were unaffected by clinically relevant self-reported pain
or the presence of diagnostically relevant MFTrPs. Dry
needling at different depths, did not alter tissue sensitiv-
ity. DDN was somewhat more effective in reducing self-
reported pain compared to SDN. Post-testing DOMS
occurred commonly and was distributed uniformly
among the cohort, where as post-needling soreness oc-
curred rarely and almost exclusively among symptom-
atic participants receiving DDN. Both self-reported pain
and tissue sensitivity were modified by the development
of DOMS.Mechanical muscle function
No differences were observed for Fmax or RFD in either
of our analyses at baseline or over time. This indicates
that neither symptom state, intervention type or post
intervention soreness significantly impacted participant
contractile characteristics. Thus, despite reporting ele-
vated levels of self-reported pain and harbouring clinic-
ally relevant myofascial MFTrPs in the neck/shoulder
area, symptomatic participants did not differ from
asymptomatic counterparts with respect to maximum
force capacity or rate of force development characteris-
tics. Therefore, it appears that participants did not ex-
perience inhibition of gross muscle contractility, due to
these factors [9].Onset of post-needling soreness and DOMS
Half the participants in this study, irrespective of symp-
tom state, reported developing post-testing DOMS.
Therefore it is likely that the increase in tissue sensitivity
presently observed, was a reaction to the process, devel-
oping after the two doses of high intensity isometric
muscle contractions elicited during the dynamometric
evaluation.
The occurrence of post-needling soreness has been
reported to range between 50 and 55%, depending on the
needling procedure used [20,33]. It was therefore interest-
ing to note a relative low occurrence rate of ≈30% in the
DDN sub-group. Furthermore, post-needling soreness
was rare amongst the remaining groups, despite the mul-
tiple needle insertions procedure used.ters
RFD- shoulder abductors RFD- shoulder elevators Age
1 2 3 1 2 3
-.036 .001 -.107 .050 -.100 -.117 1.0
.758 .996 .368 .671 .390 .327 .
post-intervention. **Correlation is significant at 0.01 (2-tailed), *Correlation is
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Dry needling (both DDN and SDN) elicited a reduction
in self-reported pain in symptomatic participants. In
contrast, asymptomatic subjects appeared to be develop-
ing pain. This was particularly noted in the case of the
asymptomatic DDN sub-group. It is likely DOMS may
have undermined observed beneficial effects in this
outcome.
Finally, our results indicate that dry needling at differ-
ent depths, did not alter tissue sensitivity either immedi-
ately after or at 48 hours post-intervention.
Active control intervention
We argued that SDN appears to have clinical effects be-
yond that of a control/placebo intervention; the effect
stemming from c-fibre inhibition, rather than direct
stimulation of the TrP nidus. Furthermore, in designing
the present study we took steps to ensure that any effect
observed from SDN could not have been due to direct
contact with muscle fibres. Thus, if both interventions
induce an indirect effect and only DDN directly affected
the myofascial tissues as indicated by the twitch re-
sponse, then it stands to reason that SDN effectively per-
formed the role of an active control in our study.
Study strengths and limitations
The observed age difference between symptomatic and
asymptomatic subjects may have affected the present
results. However, this is unlikely given the inconsistent
associations observed in the correlation analysis. Age is
thought to have negative effect on MFTrP phenomena
[34] and mechanical muscle function characteristics
[22]; therefore it is unlikely that the symptomatic partici-
pants would have benefitted from skewness in age. Our
symptom-based sub-group analysis was underpowered
based on sample size calculation. Thus, type-II errors
cannot be discounted. It is unclear from our results
whether differences exist between SDN and DDN with
respect to reducing self-reported pain as confounding
due to DOMS, may have altered tissue sensitivity mea-
surements after 48 hours. Our asymptomatic partici-
pants had also received previous treatment for their
neck pain; it would therefore be prudent to determine
neck pain status on more than self-reported pain at the
point of inclusion. More clarity is required as to whether
individuals are able to differentiate between soreness
and DOMS. Establishing clinical relevance fell outside
the scope of this study.
The present study methodology was innovative in its
use of muscle contractility outcomes that accounted not
only for maximal contractile strength (Fmax), but also for
the ability to investigate the exertion of rapid muscle
force characteristics (RFD). Interestingly, in this context
neck/shoulder pain sufferers were willing and able tocommit to three sessions of strenuous maximum volun-
tary contraction testing that were characterized by high
levels of RFD, even after reporting the onset of DOMS.
This finding appears to challenge the notion of painful
inhibition and requires further study. It also appears that
the onset of DOMS may result in an uncoupling of tissue
sensitivity and self-reported pain in symptomatic indivi-
duals. In other words, participants with sore muscles may
yet demonstrate reduced levels of subjective pain.
Conclusions
Skeletal contractile muscle function did not differ be-
tween participants harbouring diagnostically relevant
MFTrPs and without neck/shoulder pain versus partici-
pants who did not. This was apparent both at baseline
and 48-hours after a mechanical intervention via dry nee-
dle insertion. DOMS was reported uniformly in response
to muscle strength/RFD testing in half the participants.
Dry needle stimulation of clinically relevant MFTRPs,
both superficially or deeper into the skeletal muscle
reduced self-reported pain in symptomatic subjects, ap-
parently without affecting tissue sensitivity. DDN was
somewhat more effective in this regard, but post-needle
soreness in symptomatic participants was also higher
(30% versus 5%). Post-intervention DOMS was induced
uniformly among participants and is likely to have led to
poorer pain-related outcomes being observed.
Additional files
Additional file 1: Boxplot demonstrating Maximum Voluntary
Contraction (MVC) for shoulder elevation for the four intervention
sub-groups over time.
Additional file 2: Boxplot demonstrating PPT levels for the
intervention sub-groups over time.
Additional file 3: Boxplot demonstrating self-reported pain levels
for the intervention sub-groups over time.
Competing interests
We declare that no financial or other conflicts of interest exist with regard to
this work.
Authors' contributions
All authors read and approved the final manuscript.
Acknowledgements
This study was supported by The University of Southern Denmark- 55
Campusvej, Odense M, 5230, Denmark, Lundbeck Foundation- Vestagervej
17, Hellerup, 2900, Denmark, IMK General Fund- Vester Voldgade 90, 2. sal.,
1552, København V and The Foundation for Chiropractic Research and Post
Graduate Education - Dampfærgevej 22, DK-2100, Copenhagen Ø, Denmark.
We would like to acknowledge the support of the study participants who
kindly donated their time and efforts to our study.
Author details
1Institute of Sport Science and Clinical Biomechanics, University of Southern
Denmark, Fyn, Odense 5230, Denmark. 2Nordic Institute for Chiropractic and
Clinical Biomechanics, Fyn, Odense 5230, Denmark. 3Department of
Orthopeadic Surgery Odense University Hospital, University of Southern
Denmark, Fyn, Odense 5230, Denmark.
Myburgh et al. Chiropractic & Manual Therapies 2012, 20:36 Page 10 of 10
http://www.chiromt.com/content/20/1/36Received: 13 June 2012 Accepted: 31 October 2012
Published: 25 November 2012
References
1. Fejer R, Kyvik KO, Hartvigsen J: The prevalence of neck pain in the world
population: a systematic critical review of the literature. Eur Spine J 2006,
15(6):834–848.
2. Bredkjaer SR: Musculoskeletal disease in Denmark. The Danish Health and
Morbidity Survey 1986-87. Acta Orthop Scand Suppl 1991, 241:10–12.
3. Wheeler AH: Myofascial pain disorders: theory to therapy. Drugs 2004,
64(1):45–62.
4. Simons DG: Review of enigmatic MTrPs as a common cause of enigmatic
musculoskeletal pain and dysfunction. J Electromyogr Kines 2004,
14(1):95–107.
5. Treaster D, Marras WS, Burr D, Sheedy JE, Hart D: Myofascial trigger point
development from visual and postural stressors during computer work.
J Electromyogr Kines 2006, 16(2):115–124.
6. Giamberardino MA, Affaitati G, Fabrizio A, Costantini R: Myofascial pain
syndromes and their evaluation. Best Pract Res Clin Rheumatol 2011, 25
(2):185–198.
7. Myburgh C, Lauridsen HH, Larsen AH, Hartvigsen J: Standardized manual
palpation of myofascial trigger points in relation to neck/shoulder pain;
the influence of clinical experience on inter-examiner reproducibility.
Man Ther 2011, 16(2):136–140.
8. Myburgh C, Larsen AH, Hartvigsen J: A systematic, critical review of
manual palpation for identifying myofascial trigger points: evidence and
clinical significance. Arch Phys Med Rehabil 2008, 89(6):1169–1176.
9. Simons DG: Myofascial Pain and Dysfunction: The Triggerpoint Manual, vol. 1.
Philadelphia: Lippincott, Williams and Wilkins; 1999.
10. Kuan TS, Hsieh YL, Chen SM, Chen JT, Yen WC, Hong CZ: The myofascial
trigger point region: correlation between the degree of irritability and
the prevalence of endplate noise. Am J Phys Med Rehab/Assoc Acad
Physiatr 2007, 86(3):183–189.
11. Ge HY, Fernandez-de-Las-Penas C, Yue SW: Myofascial trigger points:
spontaneous electrical activity and its consequences for pain induction
and propagation. Chin Med 2011, 6:13.
12. Aagaard P, Simonsen EB, Andersen JL, Magnusson P, Dyhre-Poulsen P:
Increased rate of force development and neural drive of human skeletal
muscle following resistance training. J Appl Physiol 2002, 93(4):1318–1326.
13. Newton RU, Hakkinen K, Hakkinen A, McCormick M, Volek J, Kraemer WJ:
Mixed-methods resistance training increases power and strength of
young and older men. Med Sci Sports Exerc 2002, 34(8):1367–1375.
14. Schulte E, Kallenberg LA, Christensen H, Disselhorst-Klug C, Hermens HJ, Rau
G, Sogaard K: Comparison of the electromyographic activity in the upper
trapezius and biceps brachii muscle in subjects with muscular disorders:
a pilot study. Eur J Appl Physiol 2006, 96(2):185–193.
15. Andersen LL, Holtermann A, Jorgensen MB, Sjogaard G: Rapid muscle
activation and force capacity in conditions of chronic musculoskeletal
pain. Clin Biomech (Bristol, Avon) 2008, 23(10):1237–1242.
16. Wakefield E, Holtermann A, Mork PJ: The effect of delayed onset of
muscle soreness on habitual trapezius activity. Eur J Pain 2011, 15(6):577–
583.
17. Weerakkody NS, Whitehead NP, Canny BJ, Gregory JE, Proske U: Large-fiber
mechanoreceptors contribute to muscle soreness after eccentric
exercise. J Pain 2001, 2(4):209–219.
18. Proske U, Morgan DL: Muscle damage from eccentric exercise:
mechanism, mechanical signs, adaptation and clinical applications.
J Physiol 2001, 537(Pt 2):333–345.
19. Tough EA, White AR, Cummings TM, Richards SH, Campbell JL:
Acupuncture and dry needling in the management of myofascial trigger
point pain: a systematic review and meta-analysis of randomised
controlled trials. Eur J Pain 2009, 13(1):3–10.
20. Kalichman L, Vulfsons S: Dry needling in the management of
musculoskeletal pain. J Am Board Fam Med 2010, 23(5):640–646.
21. Hong CZ: Persistence of local twitch response with loss of conduction to
and from the spinal cord. Arch Phys Med Rehabil 1994, 75(1):12–16.
22. Arjunan S, Kumar D, Kalra C, Burne J, Bastos T: Effect of age and gender on
the surface electromyogram during various levels of isometric
contraction. In Conference proceedings: Annual International Conference of
the IEEE Engineering in Medicine and Biology Society IEEE Engineering in
Medicine and Biology Society Conference 2011.; 2011:3853–3856.23. Chen CK, Nizar AJ: Myofascial pain syndrome in chronic back pain
patients. Korean J Pain 2011, 24(2):100–104.
24. Zebis MK, Andersen LL, Pedersen MT, Mortensen P, Andersen CH, Pedersen
MM, Boysen M, Roessler KK, Hannerz H, Mortensen OS, et al:
Implementation of neck/shoulder exercises for pain relief among
industrial workers: a randomized controlled trial. BMC Musculoskelet
Disord 2011, 12:205.
25. Fejer R, Jordan A, Hartvigsen J: Categorising the severity of neck pain:
establishment of cut-points for use in clinical and epidemiological
research. Pain 2005, 119(1–3):176–182.
26. Cotchett MP, Landorf KB, Munteanu SE: Effectiveness of dry needling and
injections of myofascial trigger points associated with plantar heel pain:
a systematic review. J Foot Ankle Res 2010, 3:18.
27. Prushansky T, Handelzalts S, Pevzner E: Reproducibility of pressure pain
threshold and visual analog scale findings in chronic whiplash patients.
Clin J Pain 2007, 23(4):339–345.
28. Itoh K, Minakawa Y, Kitakoji H: Effect of acupuncture depth on muscle
pain. Chin Med 2011, 6(1):24.
29. Shah JP, Phillips TM, Danoff JV, Gerber LH: An in vivo microanalytical
technique for measuring the local biochemical milieu of human skeletal
muscle. J Appl Physiol 2005, 99(5):1977–1984.
30. Hong CZ: Lidocaine injection versus dry needling to myofascial trigger
point. The importance of the local twitch response. Am J Phys Med
Rehab/Assoc Acad Physiatr 1994, 73(4):256–263.
31. Chen JT, Chung KC, Hou CR, Kuan TS, Chen SM, Hong CZ: Inhibitory effect
of dry needling on the spontaneous electrical activity recorded from
myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehab/
Assoc Acad Physiatr 2001, 80(10):729–735.
32. Cotchett MP, Landorf KB, Munteanu SE, Raspovic A: Effectiveness of trigger
point dry needling for plantar heel pain: study protocol for a
randomised controlled trial. J Foot Ankle Res 2011, 4:5.
33. Ga H, Choi JH, Park CH, Yoon HJ: Dry needling of trigger points with and
without paraspinal needling in myofascial pain syndromes in elderly
patients. J Altern Complement Med 2007, 13(6):617–624.
34. Cummings M, Baldry P: Regional myofascial pain: diagnosis and
management. Best Pract Res Clin Rheumatol 2007, 21(2):367–387.
doi:10.1186/2045-709X-20-36
Cite this article as: Myburgh et al.: Skeletal muscle contractility, self-
reported pain and tissue sensitivity in females with neck/shoulder pain
and upper Trapezius myofascial trigger points– a randomized
intervention study. Chiropractic & Manual Therapies 2012 20:36.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
